EUR vs Guinea-Bissau: Hepatitis B surface antigen (HBsAg) prevalence
EUR
0.1%
in 2024
Guinea-Bissau
2.7%
in 2024
EUR rank
10th
Guinea-Bissau rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- EUR
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 2.7% against 0.1% in EUR, a difference of 2.6%.
That makes Guinea-Bissau's figure about 27.0 times EUR's.
Across all 10 years both countries report, Guinea-Bissau has been ahead every year.
EUR ranks 10th and Guinea-Bissau ranks 8th of 13 groups.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EUR | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 2.8% | 2.7% | Guinea-Bissau |
| 2020s | 0.1% | 2.7% | 2.6% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EUR or Guinea-Bissau?
- Guinea-Bissau, at 2.7% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EUR and Guinea-Bissau?
- 2.6%, with Guinea-Bissau ahead.
- How many years of comparable data are there for EUR and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do EUR and Guinea-Bissau rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EUR ranks 10th and Guinea-Bissau ranks 8th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.